Back to results
US 11,279,769 B2Granted
Anti-Sialyl Tn chimeric antigen receptors
AssigneeHelixmith Co., Ltd
InventorsRichard Morgan, Kevin Friedman, Seung Shin Yu, Jae-Gyun Jeong, Jin-A Chae
Life of this patent
Estimating the term…
Abstract
The invention provides improved compositions for adoptive cell therapies for cancers that express the glycoepitope STn on TAG-72.
Claims25
A chimeric antigen receptor (CAR) comprising:
- an extracellular domain that comprises:
- a) an anti-sialyl Tn (STn) antibody or antigen binding fragment thereof that binds one or more epitopes of an STn antigen expressed on a glycoprotein, wherein the anti-STn antibody or antigen binding fragment thereof comprises a variable light chain sequence comprising CDRL1-CDRL3 sequences set forth in SEQ ID NOs:
- 9-11, and a variable heavy chain sequence comprising CDRH1-CDRH3 sequences set forth in SEQ ID NOs:
- 12-14, wherein the variable light chain comprises SEQ ID NO:
- 15 or 23 and the variable heavy chain comprises SEQ ID NO:
- 16 or 24;
- b) a transmembrane domain;
- c) one or more intracellular co-stimulatory signaling domains;
- and
- d) a primary signaling domain.
7 more elements
Dependencies are inferred from the claim text.